DRUG SAFETY
ELECTRONIC SUPPLEMENTARY MATERIAL
IMPACT OF INTERVENTIONS DESIGNED TO REDUCE MEDICATION
ADMINISTRATION ERRORS IN HOSPITALS: A SYSTEMATIC REVIEW
Richard N Keers MPharm (corresponding author)1, 2
Steven D Williams MPhil1, 3
Jonathan Cooke PhD1, 4
Tanya Walsh PhD5
Darren M Ashcroft PhD1, 2
1
Centre for Pharmacoepidemiology and Drug Safety Research, Manchester Pharmacy School,
University of Manchester, Manchester, United Kingdom, M13 9PT. Tel: (+44)161 275 2414, fax:
(+44)1612752416, Email: richard.keers@manchester.ac.uk
2
NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic
Health Sciences Centre (MAHSC), University of Manchester, Manchester, United Kingdom M13
9PT.
3
Pharmacy Department, University Hospital South Manchester NHS Foundation Trust, Southmoor
Road, Wythenshawe, Manchester, United Kingdom M23 9LT.
4
Infectious Diseases and Immunity Section, Division of Infectious Diseases, Department of Medicine,
Imperial College London, United Kingdom.
5
School of Dentistry, University of Manchester, Manchester, United Kingdom M13 9PT.
Example complete search strategy for EMBASE
Ran 29/11/2013 using ‘Keyword’ search of all fields (not including full text).
Total hits: 8372
1. medication error$.mp. or exp medication error/
2. exp error/ or error$.mp.
3. drug error$.mp.
4. drug safety.mp. or exp drug safety/
5. medication safety.mp.
6. near miss$.mp.
7. adverse event$.mp.
8. adverse drug event$.mp.
9. potential adverse event$.mp.
10. potential adverse drug event$.mp.
11. preventable adverse event$.mp.
12. preventable adverse drug event$.mp.
13. ADE.mp.
14. clinical incident$.mp.
15. medication incident$.mp.
16. medical error$.mp. or exp medical error/
17. treatment error$.mp. or exp therapeutic error/
18. health care error$.mp.
19. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20. rate.mp.
21. inciden$.mp.
22. prevalen$.mp.
23. exp epidemiology/ or epidemiol$.mp.
24. 20 or 21 or 22 or 23
25. 19 and 24
26. secondary care.mp.
27. secondary.mp.
28. tertiary care.mp. or exp tertiary health care/
29. tertiary.mp.
30. hospital$.mp. or exp hospital/
31. in-patient$.mp. or exp hospital patient/
32. inpatient$.mp.
33. hospitali?ation.mp.
34. unit$.mp.
35. ward$.mp. or exp ward/
36. health center$.mp. or exp health center/
37. health centre$.mp.
38. 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37
39. randomized controlled trial/
40. controlled study/
41. RCT.mp.
42. intervention stud$.mp.
43. exp experiment/ or experiment$.mp.
44. exp time series analysis/
45. random$.mp.
46. impact$.mp.
47. intervention$.mp.
48. exp intervention study/
49. (pretest or pre test).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword]
50. (post test or posttest).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword]
51. chang$.mp.
52. evaluat$.mp.
53. evaluation stud$.mp.
54. effect$.mp.
55. comparative stud$.mp.
56. exp comparative study/
57. exp case control study/ or case control$.mp.
58. compara$.mp.
59. case stud$.mp.
60. control group$.mp. or exp control group/
61. control subject$.mp.
62. control patient$.mp.
63. omission.mp.
64. commission.mp.
65. self administration$.mp. or exp drug self administration/
66. self medicat$.mp.
67. exp self medication/
68. drug utili?ation.mp.
69. drug administ$.mp.
70. medication administration$.mp.
71. medicine administration$.mp.
72. drug prepar$.mp.
73. dose prepar$.mp.
74. medication preparation$.mp.
75. medicine prepar$.mp.
76. drug suppl$.mp.
77. medication suppl$.mp.
78. medicine suppl$.mp.
79. drug deliver$.mp.
80. medication deliver$.mp.
81. medicine deliver$.mp.
82. drug handl$.mp.
83. medication handling.mp.
84. medicine handling$.mp.
85. 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81
or 82 or 83 or 84
86. clinical trial/
87. (before and after stud$).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original
title, device manufacturer, drug manufacturer, device trade name, keyword]
88. 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57
or 58 or 59 or 60 or 61 or 62 or 86 or 87
89. 25 and 38 and 85 and 88
90. limit 89 to yr="1985 -Current"